Blood sample collection
ApprovedRecruiting 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Botulism
Conditions
Botulism
Trial Timeline
Oct 1, 2014 → Jul 31, 2028
NCT ID
NCT02051062About Blood sample collection
Blood sample collection is a approved stage product being developed by Emergent BioSolutions for Botulism. The current trial status is recruiting. This product is registered under clinical trial identifier NCT02051062. Target conditions include Botulism.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02051062 | Approved | Recruiting |
Competing Products
1 competing product in Botulism
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| BAT | Emergent BioSolutions | Pre-clinical | 15 |